GENEVA, July 18 -- MERSANA THERAPEUTICS, INC. filed a patent application (US2026/010621) for “TREATMENT OF CANCER USING B7-H4-TARGETED ANTIBODY-DRUG CONJUGATES”. With publication no. WO/2026/151884, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....